In the same year, Xiuxing Wang and colleagues performed in silico analysis of glioblastoma patients and found that SREBP2 promotes cholesterol biosynthesis in glioblastoma stem cells (GSCs), inducing cholesterol uptake at the tumor edge [107]. Here, SREBF2 is linked to neoplasm.